N-terminal pro-brain natriuretic peptide as a predictor of heart failure with preserved ejection fraction in hemodialysis patients without fluid overload

Blood Purification

Volumn 33, Issue 1-3, 2012, Pages 37-43

  Kamano, Chisako ^a,b   Osawa, Hirokazu ^a,b   Hashimoto, Kazumasa ^a   Nishimura, Shungo ^a,b   Saito, Sabiene Kyoko ^a,b   Kashiwagi, Tetsuya ^a   Iino, Yasuhiko ^a   Katayama, Yasuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Hakujikai Memorial Hospital and Clinic   (Japan)

Author keywords

Heart failure with preserved ejection fraction; Hemodialysis patient; Hydration status; Left ventricular diastolic dysfunction; N terminal pro brain natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ANALYTIC METHOD; ARTICLE; BIOELECTRICAL IMPEDANCE ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMODIALYSIS PATIENT; HUMAN; HYPERVOLEMIA; IMPEDANCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ECHOCARDIOGRAPHY, DOPPLER; HEART FAILURE; HEART VENTRICLES; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RENAL DIALYSIS; RENAL INSUFFICIENCY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; WATER-ELECTROLYTE BALANCE;

EID: 82655185107     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000333841     Document Type: Article

References (30)

1. Paulus WJ, Tschöpe C, Sanderson JE, et al: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550.
2. Tschöpe C, Kasner M, Westermann D, et al: The role of NT-pro BNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 2005; 26: 2277-2284.
3. Rostoker G, Griuncelli M, Loridon C, et al: Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension. Cardiology 2009; 114:142-149.
4. McCullough PA, Sandberg KR: Chronic kidney disease and sudden death: strategies for prevention. Blood Purif 2004; 22: 136-142.
5. Rudski LG, Lai WW, Afilalo J, et al: Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echo-cardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713.
6. Quinones MA, Waggoner AD, Reduto LA, et al: A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981; 64:744-753.
7. Nishimura RA, Tajik AJ: Evaluation of dia-stolic filling of left ventricle in health and disease: Doppler echocardiography in the clinician's Rosetta stone. J Am Coll Cardiol 1997; 30:8-18.
8. Ommen SR, Nishimura RA, Appleton CP, et al: The clinical utility of Doppler echocar-diography and tissue Doppler imaging in estimation of left ventricular filling pressures: a comparative simultaneous Doppler-cathe- terization study. Circulation 2000; 102:178 8-1794.
9. Margaret MR, Steven JJ, John CB, et al: Burden of systolic and diastolic ventricular dys-functionin the community. JAMA 20 03; 289: 194-202.
10. Murray JA, Kennedy JW, Figley MM: Quantitative angiocardiography. II. The normal left atrial volume in man. Circulation 1968; 37: 800-804.
11. Shub C, Klein AL, Zachariah PK, et al: Determination of left ventricular mass by echo-cardiography in a normal population: effect of age and sex in addition to body size. Mayo Clin Proc 1994; 69:205-211.
12. Sudoh T, Kanagawa K, Minamino N, et al: A new natriuretic peptide in porcine brain. Nature 1998; 332:78-81.
13. Swedberg K, Cleland J, Dargie H, et al: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Hear t J 2005; 26: 1115-1140.
14. Lubien E, DeMaria A, Krishnaswamy P, et al: Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
15. Zoccali C, Mallamaci F, Benedetto FA, et al: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12:1508-1515.
16. Lee JA, Kim DH, Yoo SJ, et al: Association between serum N-terminal pro-brain natri-uretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2006; 26: 360-365.
17. Robert NF, Bryan MC, Edward WR, et al: Left ventricular hypertrophy in new hemo-dialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 2010; 5: 805-813.
18. Giglioli C, Landi D, Gensini GF, Valente S, Cecchi E, Scolletta S, Chiostri M, Romano SM: Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: a preliminary report. Blood Purif 2010; 29:44-51.
19. Takase H, Dohi Y, Toriyama T, et al: B-type natriuretic peptide levels and cardiovascular risk in patients with diastolic dysfunction on chronic haemodialysis: cross-sectional and observational studies. Nephrol Dial Transplant 2011; 26: 683-690.
20. Tsutamoto T, Sakai H, Nishiyama K, et al: Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients w it h chronic hear t fai lure. Circ J 2007; 71: 1873-1878.
21. Fonseca C, Sarmento PM, Minez A, et al: Comparative value of BNP and NT-pro BNP in diagnosis of heart failure. Rev Port Car-diol 2004; 23: 979-991.
22. Paniagua R, Ventura MD, Avila-Díaz M, et al: NT-pro BNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 2010; 25:551-557.
23. Kremastinos DT, Hamodraka E, Parissis J, et al: Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. A m Heart J 2010; 159: 68-74.
24. Pemberton CJ, Johnson ML, Yandle TG, et al: Deconvolution analysis of cardiac natri-uretic peptides during acute volume overload. Hyper tension 2000; 36: 355-359.
25. Madsen LH, Ladefoged S, Corell P, et al: N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 2007; 71: 548-554.
26. Wang AY, Lam CW, Yu CM, et al: N-termi-nal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal di-a lysis patients. J Am Soc Nephrol 2007; 18: 321-330.
27. David S, Kümpers P, Seidler V, et al: Diagnostic value of N-terminal pro-B-type natri-uretic peptide (NT-pro BNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dia l Tra nsplant 2008; 23: 1370-1377.
28. Gremmler B, Kunert M, Schleiting H, et al: Relation between N-terminal pro-brain na-triuretic peptide values and invasively measured left ventricular hemodynamic indices. Exp Clin Cardiol 2003; 8:91-94.
29. Banerjee P, Banerjee T, Khand A, et al: Dia-stolic heart failure: neglected or misdiag-nosed? J Am Coll Cardiol 2002; 39:138-141.
30. Yamaguchi H, Yoshida J, Yamamoto K, et al: Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004; 43:55-60.